Stanford University
Showing 5,701-5,750 of 13,006 Results
-
Varvara A. Kirchner
Associate Professor of Surgery (Abdominal Transplantation) and, by courtesy, of Pediatrics
BioDr. Kirchner completed her medical school, surgical residency and multi-organ transplant fellowship in adult and pediatric liver, pancreas, kidney transplantation and total pancreatectomy with islet auto-transplantation at the University of Minnesota. She underwent further training in living donor liver transplantation and hepatobiliary surgery at the Asan Medical Center, Seoul, South Korea. Her clinical practice involves living and deceased donor liver and kidney transplantation in adult and pediatric patients as well as total pancreatectomy with islet auto-transplantation for patients with chronic and acute recurrent pancreatitis. She currently serves as Surgical Director of the Islet Cell Auto-Transplant at Stanford Children’s and Associate Director of the Living Donor Liver Transplant Program at the Division of Abdominal Transplantation. Dr. Kirchner’s research focuses on the biology of aging, cellular and solid organ transplantation. Her specific interests are in auto-islet transplantation, iPSC-derived hepatocyte therapies and liver regeneration. Dr. Kirchner's research on the impact of donor age on generation of iPSC-derived hepatocyte-like cells is supported by the NIA K08 Faculty Development Award. She is an active member of the American Society of Transplant Surgeons and the International Liver Transplantation Society.
-
Karla Kirkegaard
Violetta L. Horton Professor and Professor of Microbiology and Immunology
Current Research and Scholarly InterestsThe biochemistry of RNA-dependent RNA polymerase function, the cell biology of the membrane rearrangements induced by positive-strand RNA virus infection of human cells, and the genetics of RNA viruses, which, with their high error rates, live at the brink of error catastrophe, are investigated in the Kirkegaard laboratory.
-
Hannah Louise Kirsch, MD
Clinical Associate Professor, Adult Neurology
BioHannah Louise Kirsch, MD is a board-certified neurologist and a Clinical Assistant Professor in the Neurocritical Care Division of the Department of Neurology & Neurological Sciences at Stanford University School of Medicine.
Dr. Kirsch is also a hospitalist who pays special attention to delivering Stanford Health Care patients the best possible neurological care.
She serves on the National Institute of Neurological Disorders and Stroke committee dedicated to coma and conditions related to consciousness. She has implemented numerous neurology-centered educational activities for health care professionals from diverse specialties, including training psychiatrists on the neuropsychiatric complications of COVID-19. She also has helped educate oncologists and hematologists regarding common neurological conditions among cancer patients.
Dr. Kirsch has conducted research on a range of topics, including thrombotic complications in critically ill COVID-19 patients, advances in intracranial pressure monitoring, and predictors of outcomes in acute encephalitis. She has published her findings in Neurology, the Journal of Trauma, Emergency Medicine, and Procedures, among other journals.
She has given presentations on topics including variations in coagulation among patients with cerebral hemorrhage and the association of cerebral pressure with cardiac arrest. She has shared her discoveries at meetings of the Neurocritical Care Society and Society of Hospital Medicine.
The Neurocritical Care Society has honored her work. She also won the prestigious Leonard Tow Humanism in Medicine Award, which recognizes clinical excellence, outstanding compassion in the delivery of care, and respect for patients, families, and health care colleagues.
Dr. Kirsch received her medical degree from New York University. She completed her residency in neurology at the University of California, San Francisco, and a fellowship in neurocritical care at Columbia University. She also completed the Columbia University narrative medicine certificate program and is board certified in neurology by the American Board of Psychiatry and Neurology. -
Derek M. Klarin, MD
Member, Cardiovascular Institute
BioDr. Klarin is a fellowship-trained vascular surgeon.
For each patient, he develops a comprehensive, compassionate care plan customized to individual needs. His goal is to help each patient achieve the best possible health and quality of life.
Dr. Klarin performs the full spectrum of diagnostic and treatment procedures for cardiovascular conditions. He treats carotid disease, peripheral artery disease, abdominal aortic aneurysm, venous thromboembolism, and other vascular diseases.
To help advance his field, Dr. Klarin has conducted research. The American Heart Association, Howard Hughes Medical Institute, and other organizations have provided grants to support his studies. He also has co-patented advances in predicting and scoring risk factors for cardiovascular disease and other conditions.
He has published extensively and co-authored more than 50 articles on new techniques and technology for diagnosing and treating cardiovascular disorders. His work has appeared in the Journal of Vascular Surgery, Circulation, JAMA, Nature Medicine, and other peer-reviewed journals.
He also has made many invited presentations to his peers. He has spoken at the Vascular Research Initiatives Conference presented by the Society for Vascular Surgery, the American Heart Association Scientific Sessions, and the annual meeting of the American Society for Human Genetics. Topics include risk factors for peripheral artery disease, the benefits of ultrasound screening for abdominal aortic aneurysm, and the impact of genetic variations on cardiovascular disease.
He is a member of the Global Lipids Genetics Consortium. He is a founding member of the Abdominal Aortic Aneurysm Genetics Consortium and the Peripheral Artery Disease Genetics Consortium. He is also a candidate member of the Society for Vascular Surgery. -
Jeffrey Howard Kleck
Adjunct Professor, Rad/Molecular Imaging Program at Stanford
BioDr. Jeff Kleck
Current Roles
Adjunct Professor, Stanford University School of Medicine — Stanford, California
Senior Partner, Eleven of Ten (Elevens) — Menlo Park, California
Chairman, Open Power & Energy Network (OPEN) — Washington, District of Columbia
Senior Advisor, United States Department of War (US DoW) — Pentagon, Arlington, Virginia
Previous Academic Appointments
Dean of Academics, Catholic Institute of Technology (CIT) — Cambridge, Massachusetts & Castel Gandolfo, Italy
Adjunct Associate Professor, University of California, Los Angeles (UCLA)
Visiting Scientist, Lawrence Berkeley National Laboratory (LBNL)
Visiting Scientist, Los Alamos National Laboratory (LANL)
Previous Commercial Technology Ventures
President and Board Member, Rapid AI
Founder, CEO, and Chairman of the Board, Attainia
Founder, CEO, and Chairman of the Board, Neoforma
Previous Government Service
Senior Advisor, United States Department of Defense (US DoD)
Director, Defense Innovation Unit (DIU), United States Department of Defense (US DoD)
Education
Ph.D., Biomedical Physics, University of California, Los Angeles (UCLA)
M.S., Engineering Management, Stanford University, Stanford
M.S., Nuclear Engineering, Texas A&M University, College Station (TAMU)
B.S., Nuclear Engineering, Texas A&M University, College Station (TAMU)
St. John's University, Collegeville (SJU)
The University of Texas, Austin (UT)
Awards in Current Roles
Ukraine Foreign Military Medal, bestowed by the Commander of the Ukraine Armed Forces (2023)
U.S. Department of Defense Award for Team Cyber & IT Excellence, bestowed by the US DoD Chief Information Officer (2019) -
John Kleimeyer, MD
Clinical Assistant Professor, Orthopaedic Surgery
BioDr. Kleimeyer specializes in orthopaedic spine surgery, treating cervical, thoracic and lumbar spine disorders including disc herniations, stenosis, myelopathy, fractures, scoliosis and more. He treats both simple and complex spine problems including revisions. His goal is to provide the most minimally invasive solution to improve patients’ quality of life. This includes less invasive discectomies, decompressions, disc replacements, and fusions. He is particularly focused on single-position procedures to limit surgical time and recovery.
Prior to coming to the Stanford Department of Orthopaedic Surgery and the Stanford Spine Center, Dr. Kleimeyer completed his residency in orthopaedic surgery at Stanford University where he was elected to the Alpha Omega Alpha honor society. He then completed his spine fellowship at the renowned Emory University Spine Center. He is board-certified.
Dr. Kleimeyer has received honors and recognition for his research in the fields of orthopaedic surgery and spine surgery. He participates in national and international specialty societies and as a journal reviewer. His research interests include improving clinical outcomes of surgical and nonsurgical care, the genetics of orthopaedic and spine disorders, and cost efficacy. Dr. Kleimeyer has published over 20 journal articles in addition to other reviews and textbook chapters, and has presented research nationally and internationally. -
Jonathan D Klein
Marron and Mary Elizabeth Kendrick Professor of Pediatrics
Current Research and Scholarly InterestsMy studies address:
1. Confidentiality and Access to Care studies of confidential time during well-visits and policy analyses addressing quality of care and health systems capacity for adolescents and young adults in the US and globally; and,
2, Tobacco, nicotine, and second-hand smoke studies of primary care counseling to reduce nicotine addiction in adolescents and programs to engage medical specialty groups in secondhand smoke clinical and policy interventions. -
Teri Klein
Professor (Research) of Biomedical Data Science, of Medicine (Computational Medicine) and, by courtesy, of Genetics
Current Research and Scholarly InterestsCo-founder, Pacific Symposium on Biocomputing
NIEHS, Site Visit Reviewer
NIH, Study Section Reviewer -
Nathan Kline
Adolescent Screenomics Study Coordinator, Peds/Disease Prevention
Current Role at StanfordAs the Adolescent Screenomics Study Coordinator, I have collaborated with Dr. Tom Robinson and the rest of the Stanford Solutions Lab team to create the groundwork for the Adolescent Screenomics study. Some of this groundwork includes: developing and maintaining a RedCap project with over 20 instruments and over 800 notifications with branching logic. I also have been collaborating with programmers and RedCap administrators to manage compensation related to smartphone use, create a zoom scheduler to onboard adolescent participants, and automate the distribution of gift cards. Moreover, I have been developing and maintaining our study website. Finally, I have been developing advertisements on Facebook, Instagram, etc. to advertise for our study. Once our study is approved by the IRB officially, I will begin recruiting and onboarding adolescent participants, obtaining informed consent (from their parents/guardians) and assent, and monitoring completion of the study.
-
Samantha M.R. Kling
Quantitative Research Scientist, Medicine - Primary Care and Population Health
Current Role at StanfordQuantitative Research Scientist in the Evaluation Sciences Unit (ESU)
-
Hanna Maria Knihtila
Instructor, Pediatrics - Immunology
BioHanna Knihtilä is an Instructor in Allergy and Immunology at Stanford. She gained her MD in 2017 and PhD in 2018 from the University of Helsinki, Finland. She then completed her 2-year postdoctoral research fellowship at the Channing Division of Network Medicine, Brigham and Women's Hospital and Harvard Medical School, before joining Stanford for her residency and fellowship training.
-
Joshua W. Knowles
Associate Professor of Medicine (Cardiovascular Medicine)
Current Research and Scholarly InterestsGenetic basis of coronary disease
Genetic basis of insulin resistance
Familial Hypercholesterolemia (FH) -
Juliet Klasing Knowles
Assistant Professor of Neurology and Neurological Sciences (Pediatric Neurology) and of Pediatrics
Current Research and Scholarly InterestsThe Knowles lab studies how white matter structure changes in different forms of epilepsy, and how aberrant white matter structure, in turn, shapes neuronal network function. In mouse models, we use a variety of innovative tools including neurophysiology, quantitative EEG, behavior, histological measures of white matter structure and MR imaging. We also conduct clinical research to study white matter abnormalities in children with epilepsy.
-
Lisa Marie Knowlton, MD, MPH, FACS, FRCSC
Associate Professor of Surgery (General Surgery)
BioDr. Knowlton is an Associate Professor of Surgery and an Acute Care Surgeon whose practice encompasses trauma surgery, emergency general surgery and surgical critical care. She is an NIH and ARPA-H funded researcher whose focus is on improving access to innovative, high-quality surgical care. She obtained her medical degree at McGill University and completed her general surgery residency at the University of British Columbia in Vancouver, Canada. Her desire to understand varied healthcare systems and develop policy solutions led her to obtain an M.P.H. at the Harvard T.H. Chan School of Public Health and complete a research fellowship at the Harvard Humanitarian Initiative. After training as a Surgical Critical Care fellow at Stanford University Medical Center, she joined the faculty as an Assistant Professor of Surgery in early 2018. She was promoted to Associate Professor in the University Medical Line in 2023. Her institutional leadership roles include serving as the Unit Based Medical Director of the Surgical Intensive Care Unit, the Associate Vice Chair of Research for the Stanford Department of Surgery, the SHC Surgical AI Lead for Early Clinical Deterioration, and the Associate Program Director for the Surgical Critical Care fellowship.
Dr. Knowlton is board certified by the American Board of Surgery and the Royal College of Physicians and Surgeons of Canada. Dr. Knowlton’s areas of clinical interest include developing safe surgical solutions for anatomic visualization in the operating room, artificial intelligence prediction tools for detection early clinical deterioration of surgery patients, optimizing the management of critically ill patients and reducing venous thromboembolism events.
Her research focuses on improving access to high-quality and high-value surgical care, merging expertise in health economics, and artificial intelligence to implement surgical innovations and health policy interventions. She leads novel work with the Department of Health Care Services focused on improving healthcare access and utilization through emergency Medicaid programs.
Dr. Knowlton’s research lab (https://med.stanford.edu/knowlton-lab.html) is funded by the Advanced Research Projects Agency for Health (ARPA-H), the National Institute of Health (NIMHD) through R21 and R01 grants, and the California Violence Prevention Center. She has also held funding through PCORI, the Department of Defense, the American College of Surgeons (the 17th C. James Carrico Faculty Research Fellowship), and the American Association for the Surgery of Trauma (AAST).
https://surgery.stanford.edu/news2/Knowlton-ARPA-H.html
She is active in national and international professional surgical societies, and recently served as the inaugural Chair of the Associate Member Council of the AAST. Dr. Knowlton has been recognized by the Association of Women Surgeons as both a ‘Shining Star’ and ‘Breaking the Glass Ceiling’ Leadership Scholar. She is also an American College of Surgeons Health Policy Scholar. Most recently, Dr. Knowlton was also selected as the 2023-24 U.S. ambassador for the James IV Surgical Association Traveling Fellowship program, where she will travel internationally to foster clinical and research collaborations. -
Susan Knox
Associate Professor of Radiation Oncology, Emerita
Current Research and Scholarly InterestsOur interests include 1) study of the effect of radiation on regulatory cell subpopulations and co-stimulatory molecules, 2) use of radiation as an immune modulator for optimization of transplant regimens, 3) the role of radiation in tumor vaccine strategies, 4) study of new radiosensitizers and radioprotectors, and 5) discovery of new targeted therapies for the treatment of solid tumors.
